Christina Lake Cannabis Corp. specializes in growing, processing, and selling cannabis products in British Columbia. Key concerns include a negative net margin of -10.0% and low return metrics (ROE: -4.6%, ROA: -2.2%), indicating profitability challenges. However, a gross margin of 28.5% suggests potential for operational efficiency. The current ratio of 1.33 reflects adequate liquidity, but a quick ratio of 0.46 raises concerns about short-term obligations. Overall, while there are strengths in margins, the company faces significant profitability and liquidity challenges.
Loading financial metrics...
Gross profit margin declined from 49.9% to 30.1% year-over-year, suggesting pricing pressure or rising input costs are squeezing profitability.
Debt of $7.9M is 4.9x the company's cash position of $1.6M.
Operating margin expanded by 42.5pp, demonstrating strong operational leverage.
Operating margin of 27.2% demonstrates excellent operational efficiency.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2027-Q1 (May 31, 2026)